TY - JOUR
T1 - Targeting Na,K-ATPase-Src signaling to normalize cerebral blood flow in a murine model of familial hemiplegic migraine
AU - Staehr, Christian
AU - Guldbrandsen, Halvor Østerby
AU - Homilius, Casper
AU - Johnsen, Laura Øllegaard
AU - Postnov, Dmitry
AU - Pedersen, Tina M
AU - Pierre, Sandrine
AU - Sandow, Shaun L
AU - Matchkov, Vladimir V
PY - 2024/12/4
Y1 - 2024/12/4
N2 - Familial hemiplegic migraine type 2 (FHM2) is linked to Na,K-ATPase α
2 isoform mutations, including that of G301R. Mice heterozygous for this mutation (
α
2
+
/
G3
0
1R
) show cerebrovascular hypercontractility associated with amplified Src kinase signaling, and exaggerated neurovascular coupling. This study hypothesized that targeting Na,K-ATPase-dependent Src phosphorylation with pNaKtide would normalize cerebral perfusion and neurovascular coupling in
α
2
+
/
G3
0
1R
mice. The effect of pNaKtide on cerebral blood flow and neurovascular coupling was assessed using laser speckle contrast imaging in awake, head-fixed mice with cranial windows in a longitudinal study design. At baseline, compared to wild type,
α
2
+
/
G3
0
1R
mice exhibited increased middle cerebral artery tone; with whisker stimulation leading to an exaggerated increase in sensory cortex blood flow. No difference between genotypes in telemetrically assessed blood pressure occurred. The exaggerated neurovascular coupling in
α
2
+
/
G3
0
1R
mice was associated with increased K
ir2.1 channel expression in cerebrovascular endothelium. Two weeks pNaKtide treatment normalized cerebral artery tone, endothelial K
ir2.1 expression, and neurovascular coupling in
α
2
+
/
G3
0
1R
mice. Inhibition of the Na,K-ATPase-dependent Src kinase signaling with pNaKtide prevented excessive vasoconstriction and disturbances in neurovascular coupling in
α
2
+
/
G3
0
1R
mice. pNaKtide had only minor hypotensive effect similar in both genotypes. These results demonstrate a novel treatment target to normalize cerebral perfusion in FHM2.
AB - Familial hemiplegic migraine type 2 (FHM2) is linked to Na,K-ATPase α
2 isoform mutations, including that of G301R. Mice heterozygous for this mutation (
α
2
+
/
G3
0
1R
) show cerebrovascular hypercontractility associated with amplified Src kinase signaling, and exaggerated neurovascular coupling. This study hypothesized that targeting Na,K-ATPase-dependent Src phosphorylation with pNaKtide would normalize cerebral perfusion and neurovascular coupling in
α
2
+
/
G3
0
1R
mice. The effect of pNaKtide on cerebral blood flow and neurovascular coupling was assessed using laser speckle contrast imaging in awake, head-fixed mice with cranial windows in a longitudinal study design. At baseline, compared to wild type,
α
2
+
/
G3
0
1R
mice exhibited increased middle cerebral artery tone; with whisker stimulation leading to an exaggerated increase in sensory cortex blood flow. No difference between genotypes in telemetrically assessed blood pressure occurred. The exaggerated neurovascular coupling in
α
2
+
/
G3
0
1R
mice was associated with increased K
ir2.1 channel expression in cerebrovascular endothelium. Two weeks pNaKtide treatment normalized cerebral artery tone, endothelial K
ir2.1 expression, and neurovascular coupling in
α
2
+
/
G3
0
1R
mice. Inhibition of the Na,K-ATPase-dependent Src kinase signaling with pNaKtide prevented excessive vasoconstriction and disturbances in neurovascular coupling in
α
2
+
/
G3
0
1R
mice. pNaKtide had only minor hypotensive effect similar in both genotypes. These results demonstrate a novel treatment target to normalize cerebral perfusion in FHM2.
U2 - 10.1177/0271678X241305562
DO - 10.1177/0271678X241305562
M3 - Journal article
C2 - 39628316
SN - 0271-678X
SP - 271678X241305562
JO - Journal of Cerebral Blood Flow and Metabolism
JF - Journal of Cerebral Blood Flow and Metabolism
ER -